This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report segregates the infertility drugs and devices industry in terms of products, technology and geography. We have used a combination of primary and secondary research to arrive at the market estimates, market shares and trends. We have adopted bottom up model to derive market size of the global infertility drugs and devices market and further validated numbers with the key market participants and C-level executives. 

• Definition, estimates and forecast of infertility drugs and devices market from 2010 to 2017
• Analysis of product segments for infertility drugs and devices market with historical data and forecast
• Trends and forecast for four geographic markets, namely North America, Europe, Asia Pacific and the RoW regions based on segments of infertility drugs and devices market
• Profiles of major market participants for better understanding of their contributions

This research is specially designed to estimate and analyze the demand and performance of infertility drugs and devices in a global scenario. The research provides in-depth analysis of infertility drugs and devices manufacturers, product sales, trend analysis by segments and demand by geography. The report covers all the major product segments of the global infertility drugs and devices market and provide in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global infertility drugs and devices market as below:

Female

• Endometriosis
• Ovarian Disorders
• Uterine Disorders
• Tubal Disorders
• Hormonal Disorders

Male

• Azoospermia
• Varicocele
• Ejaculation Disorder
• Erectile Dysfunction

Infertility Drugs and  Devices by Technology

• Assisted Reproductive Technologies
• In Vitro Fertilization
• Artificial Insemination
• Surgery 

Infertility Drugs and  Devices Market by Geography

Europe Infertility Drugs and Devices Market

• U.K
• France
• Germany
• Italy
• Spain

North America Infertility Drugs And Devices Market

• U.S
• Canada
• Mexico

Asia Pacific Infertility Drugs And Devices Market

• Japan
• India
• China

Row Infertility Drugs And Devices Market

• Brazil’s 

The in-depth research and high level analysis will allow infertility drugs and device manufacturers, lawmakers, large retailers, medical companies and research and development agencies to make informed decisions about infertility drugs and devices manufacturing, designing marketing, growth strategies and gaining competitive advantage.

1.1 KEY POINTS COVERED

1.2 REPORT DESCRIPTION

1.3 RESEARCH METHODOLOGY

3.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND) AND ANNUAL GROWTH RATE, 2010 – 2017

3.1.1 COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES MARKET, 2010 V/S 2017

3.1.2 GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 – 2017

GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 – 2017

3.2 POPULATION GROWTH TREND

3.2.1 GLOBAL MALE AND FEMALE POPULATION GROWTH TREND BY AGE GROUP

3.2.2 INFERTILITY DRUGS AND DEVICES MARKET ATTRACTIVENESS ANALYSIS BY GEOGRAPHY

3.3 CAUSES OF INFERTILITY

3.4 MARKET DYNAMICS

3.4.1 DRIVERS

3.4.1.1 Rising number of infertile people

3.4.1.2 Increasing worldwide obesity

3.4.1.3 Rising disposable incomes of the consumers

3.4.1.4 Lifestyle hazards such as rising number of smokers, stress and pollution

3.4.1.5 Adoption of babies by homosexual couples

3.4.1.6 Availability of government support for infertility abatement procedures

3.4.2 INFERTILITY DRUGS AND DEVICES MARKET DRIVER IMPACT ANALYSIS

3.4.3 RESTRAINTS

3.4.3.1 Limited insurance covers

3.4.3.2 Religious bans on artificial insemination procedures especially the Islamic bans

3.4.3.3 Risk of repeat procedures

3.4.3.4 Traditional infertility treatments such as the Chinese infertility treatments

3.4.3.5 Ban on artificial reproduction procedures in European countries especially Turkey, Germany, Italy and France

3.4.3.6 Patent expiration of infertility drugs

3.4.4 INFERTILITY DRUGS AND DEVICES MARKET RESTRAINTS IMPACT ANALYSIS

3.4.5 OPPORTUNITY

3.4.5.1 Technological advancements in the Asia Pacific region and the developmental activities in the region

3.4.5.2 Medical tourism initiatives in the developing countries

3.4.5.3 Need for more ART cycles

3.1 MARKET SHARE ANALYSIS, 2011

3.2 PORTER’S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES MARKET

3.2.1 BARGAINING POWER OF SUPPLIERS

3.2.1 BARGAINING POWER OF BUYERS

3.2.2 THREAT OF NEW ENTRANTS

3.2.3 THREAT OF SUBSTITUTES

3.2.4 COMPETITIVE RIVALRY

4.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY TYPES

4.1.1 FEMALE INFERTILITY POPULATION PREVALENCE BY TYPES

4.1.1.1 Global Infertility drugs and devices market by Endometriosis female infertility types

4.1.1.2 Global Infertility drugs and devices market by Ovarian disorder female infertility types

4.1.1.3 Global Infertility drugs and devices market by Uterine disorder female infertility types

4.1.1.4 Global Infertility drugs and devices market by Tubal disorder female infertility types

4.1.1.5 Global Infertility drugs and devices market by Hormonal disorder female infertility types

4.1.2 MALE INFERTILITY POPULATION PREVALENCE BY TYPES

4.1.2.1 Global Infertility drugs and devices market by Azoospermia male infertility types

4.1.2.2 Global Infertility drugs and devices market by Varicocele male infertility types

4.1.2.3 Global Infertility drugs and devices market by Ejaculation Disorder male infertility types

4.1.2.4 Global Infertility drugs and devices market by Erectile Dysfunction male infertility types

4.2 INFERTILITY DRUGS AND DEVICES MARKET BY TECHNOLOGY

4.2.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION

4.2.2 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ASSISTED REPRODUCTIVE TECHNOLOGIES (USD THOUSAND) 

4.2.3 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY IN VITRO FERTILIZATION (USD THOUSAND) 

4.2.4 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY SURGERY (USD THOUSAND) 57

5.1 INFERTILITY DRUGS AND DEVICES MARKET BY REGION

5.1.1 EUROPE INFERTILITY DRUGS AND DEVICES MARKET

5.1.1.1 U.K

5.1.1.2 France

5.1.1.3 Germany

5.1.1.4 Italy

5.1.1.5 Spain

5.1.2 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET

5.1.3 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET

5.1.3.1 U.S

5.1.3.2 CANADA

5.1.3.3 MEXICO

5.1.4 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET

5.1.5 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET

5.1.5.1 Japan

5.1.5.2 India

5.1.5.3 China

5.1.6 ROW INFERTILITY DRUGS AND DEVICES MARKET

5.1.7 ROW INFERTILITY DRUGS AND DEVICES MARKET

  5.1.7.1 Brazil’s Infertility drugs and devices market

6.1 JOHNSON & JOHNSON

6.1.1 COMPANY OVERVIEW

6.1.2 FINANCIAL OVERVIEW

6.1.3 BUSINESS STRATEGIES

6.1.4 RECENT DEVELOPMENTS

6.2 MERCK

6.2.1 COMPANY OVERVIEW

6.2.2 FINANCIAL OVERVIEW

6.2.3 BUSINESS STRATEGIES

6.2.4 PRODUCT PORTFOLIO

6.2.5 RECENT DEVELOPMENT

6.3 TEVA PHARMACEUTICALS

6.3.1 COMPANY OVERVIEW

6.3.2 FINANCIAL OVERVIEW

6.3.3 BUSINESS STRATEGIES

6.3.4 PRODUCT PORTFOLIO

6.3.5 RECENT DEVELOPMENTS

6.4 ORIGIO

6.4.1 COMPANY OVERVIEW

6.4.2 FINANCIAL OVERVIEW

6.4.3 BUSINESS STRATEGIES

6.4.4 PRODUCT PORTFOLIO

6.4.5 RECENT DEVELOPMENTS

6.5 BAYER

6.5.1 COMPANY OVERVIEW

6.5.2 FINANCIAL OVERVIEW

6.5.3 BUSINESS STRATEGIES

6.5.4 PRODUCT PORTFOLIO

6.5.5 RECENT DEVELOPMENT

TABLE 1 IMPACT ANALYSIS OF DRIVERS

TABLE 2 IMPACT ANALYSIS OF RESTRAINTS

TABLE 3 GLOBAL FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 

TABLE 4 GLOBAL MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 

TABLE 5 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 

TABLE 6 U.K  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 

TABLE 7 U.K POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 

TABLE 8 U.K MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 

TABLE 9 U.K FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 

TABLE 10 U.K INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 

TABLE 11 U.K INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 

TABLE 12 FRANCE INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 

TABLE 13 FRANCE POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 

TABLE 14 FRANCE MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 

TABLE 15 FRANCE FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 

TABLE 16 FRANCE INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 

TABLE 17 FRANCE INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 

TABLE 18 GERMANY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 

TABLE 19 GERMANY POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 

TABLE 20 GERMANY MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 

TABLE 21 GERMANY FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 

TABLE 22 GERMANY INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND 

TABLE 23 GERMANY INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 

TABLE 24 ITALY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 

TABLE 25 ITALY POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 

TABLE 26 ITALY MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 

TABLE 27 ITALY FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 

TABLE 28 ITALY INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 

TABLE 29 ITALY INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 

TABLE 30 SPAIN INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 

TABLE 31 SPAIN POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 

TABLE 32 SPAIN MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 

TABLE 33 SPAIN FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 

TABLE 34 SPAIN INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 

TABLE 35 SPAIN INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 

TABLE 36 U.S INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 

TABLE 37 U.S POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 

TABLE 38 U.S MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 

TABLE 39 U.S MALE INFERTILITY POPULATION TREATED, 2010 - 2017 (THOUSAND) 

TABLE 40 U.S FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 

TABLE 41 U.S INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 

TABLE 42 U.S INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 

TABLE 43 CANADA INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 

TABLE 44 CANADA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 

TABLE 45 CANADA MALE INFERTILITY POPULATION PREVALENCE 2010 - 2017 (THOUSAND) 

TABLE 46 CANADA FEMALE INFERTILITY POPULATION PREVALENCE, 2010 – 2017 (THOUSAND) 

TABLE 47 CANADA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 

TABLE 48 CANADA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 

TABLE 49 MEXICO INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 

TABLE 50 MEXICO POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 

TABLE 51 MEXICO MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 

TABLE 52 MEXICO FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND) 

TABLE 53 MEXICO INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 

TABLE 54 MEXICO INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 

TABLE 55 JAPAN  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 

TABLE 56 JAPAN POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 

TABLE 57 JAPAN MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 

TABLE 58 JAPAN FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (MILLION) 

TABLE 59 JAPAN INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 

TABLE 60 JAPAN INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD MILLION) 

TABLE 61 INDIA  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 

TABLE 62 INDIA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 

TABLE 63 INDIA MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND

TABLE 64 INDIA FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND) 

TABLE 65 INDIA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 

TABLE 66 INDIA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 

TABLE 67 CHINA  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 

TABLE 68 CHINA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 

TABLE 69 CHINA MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 

TABLE 70 CHINA FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 

TABLE 71 CHINA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 

TABLE 72 CHINA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 

TABLE 73 ROW  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 

TABLE 74 ROW FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 

TABLE 75 ROW INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 

TABLE 76 BRAZIL  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 

TABLE 77 BRAZIL POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 

TABLE 78 BRAZIL MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 

TABLE 79 BRAZIL FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 

TABLE 80 BRAZIL INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 

TABLE 81 BRAZIL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 

FIG. 1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND) AND ANNUAL GROWTH RATE, 2010 – 2017 (%) 

FIG. 2 COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES MARKET SHARE, 2010 VS 2017 

FIG. 3 GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 

FIG. 4 GLOBAL POPULATION TREND, MALE AND FEMALE POPULATION TREND, 2010 – 2017 (THOUSANDS) 

FIG. 5 GLOBAL FERTILE MALE AND FEMALE POPULATION TREND, 2010 – 2017 (THOUSANDS) 

FIG. 6 GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 

FIG. 7 MARKET ATTRACTIVENESS - INFERTILITY DRUGS AND DEVICES MARKET BY GEOGRAPHY 

FIG. 8 CAUSES OF INFERTILITY 

FIG. 9 PORTER’S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES MARKET 

FIG. 10 COMPARITIVE ANALYSIS OF INFERTILITY DRUGS AND DEVICES MARKET SHARE BY GEOGRAPHY, 2010 AND 2017 (%) 

FIG. 11 EUROPE INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 

FIG. 12 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 

FIG. 13 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 

FIG. 14 DECLINING FERTILITY RATE IN JAPAN, 2007 - 2011 

FIG. 15 ROW INFERTILITY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 

FIG. 16 JOHNSON & JOHNSON’S ANNUAL SALES, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 – 2010 (%) 

FIG. 17 MERCK’S ANNUAL REVENUE, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 - 2010 (%) 

FIG. 18 TEVA PHARMACEUTICAL’S ANNUAL REVENUE, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 - 2010 (%) 

FIG. 19 ORIGIO’S ANNUAL REVENUE, 2010 – 2011 (USD MILLION) 

FIG. 20 BAYER’S ANNUAL SALES, 2010 – 2011 (USD MILLION)